Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M703101 Phase III Study in Infantile Hemangiomas
jRCT2080222409Phase 3
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of atenolol in Capillary Haemangioma, sponsored by Maruho Co., Ltd.
02
Drugs
atenolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on jRCT2080222409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222409.